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Abstract
This article presents a new approach to ambulatory arrhythmia monitoring, one which can be
viewed as a natural evolution of the existing non-invasive methods for diagnosing heart
rhythm abnormalities. This new method combines the real-time capabilities of modern mobile
cardiovascular telemetry systems with a quantitative way of reporting measured findings and
continuous storage of the ECG data typical of Holter monitoring systems. It further combines
this with a symptom-reporting capability typical of event monitoring applications. Combining
all these features produces a single device which could be described as the ultimate arrhythmia
diagnostic tool. (Cardiol J 2011; 18, 4: 454–460)
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Introduction
Ambulatory monitoring is used to diagnose
syncope and palpitations, and identify ventricular
ectopy and non-sustained ventricular tachycardia
[1]. Atrial fibrillation (AF) has become the common-
est indication for ambulatory monitoring, especial-
ly to monitor the safety and efficacy of pharmaco-
logical and non-pharmacological therapies [2, 3], or
to identify asymptomatic AF as an underlying cause
of cryptogenic stroke [4, 5].
Ambulatory arrhythmia monitoring was invent-
ed by Norman J. Holter [6] in 1949 for diagnosing
patients with suspected cardiac arrhythmias. Initial-
ly, the device had very large batteries and the tape
recorder weighed roughly 75 lbs (35 kg). Clinical
use of the device began in the early 1960s [6]. It
could record a single lead signal for less than 24 h.
The clinical need for time-extended monitoring has
resulted in technological advances over the past
50 years. Today, clinicians utilize the latest mobile
data transmission technologies, the internet,
advanced digital signal processing techniques and
artificial intelligence including artificial neural net-
work self-learning algorithms.
Today, clinicians can benefit from real-time
access to data and can choose for how long a study
should be carried out. Based on the generated re-
sults, the monitoring session can be terminated at
any time — after a day, a week or even a month —
once the conclusive data has been collected. Also,
the latest mobile telephony network technologies
allow for the transmission of large packets of data,
making the devices truly mobile and simpler to use
for the patients.
Review of non-invasive ambulatory
arrhythmia diagnostic methods
Holter monitoring (HM) systems
HM is a continuous monitoring device that
stores the entire ECG signal in memory for further
analysis when the patient returns the device to the
healthcare provider. Today’s HM systems utilize
small and lightweight recorders that allow for moni-
toring over several days or even up to  two weeks.
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Storage capacity of the memory cards used by the
modern devices is no longer the technological limi-
tation of the monitors. After collecting the data, the
digitized ECG signal is downloaded onto a compu-
ter and automatically processed using advanced data
processing software. The process is supervised by
a trained specialist. The biggest advantage of the
Holter system is its ability to access continuous
ECG data and quantitative representation of the
analysis results. HMs automatically recognize
PQRST complexes morphology and count all patho-
logical and normal beats. This allows for reporting
of the results in a numerical format, where a single
page of the report presents results of analysis per-
formed on thousands of heartbeats. The numerical
summary is supported by selected ECG sample
examples and the entire report normally covers no
more than a few pages, which saves the physician’s
time, and is thus  cost-effective. Another advantage
of HM is its ease of use for the patient — the re-
cording does not require the patient to transmit the
data or charge the batteries of the monitor.
The biggest limitation of this monitoring me-
thod is an inability to access the ECG data in real time
— the recording duration has to be determined in
advance. Another limitation of HM for an extended
period of time is ECG signal quality and lack of com-
pliance from the patient, something that is a parti-
cular problem for monitoring sessions longer than
24/48 h [7, 8]. Since this monitoring method does
not allow for accessing data in real time, it is im-
possible to control the recording quality, making it
impractical to use the devices for an extended pe-
riod of time [1, 9–12].
Event monitoring: Non-looping memory
(EMNL) systems
EMNLs are patient-activated intermittent
monitoring systems that do not require the patient
to constantly wear electrode patches. Once the
symptomatic event occurs, the device should be
attached to the patient’s skin e.g. chest, thumbs,
wrists, etc. to store the relevant ECG data. Then
the stored data has to be transmitted via a telephone
to the healthcare provider for analysis. The biggest
advantage of this type of device is that they are
comfortable for the patient and are suitable for pa-
tients with sensitive skin, or for patients unable to
manage the electrode patches. Normally, EMNLs
have up to 6 min of memory, and can be used for an
extended period of time and allow for almost real-
-time access to the data, which is another advantage
of this monitoring method.
The biggest limitation of the intermittent non-
-looping memory monitor is the delay in recording
the symptomatic ECG data: when the patient feels
the symptom, places the monitor, and then press-
es the button, it is often too late to capture the
event. This type of monitor is not intended to cap-
ture pre-event data. Another limitation of EMNLs
is related to compliance, in that they require some
level of technical skill from the patient. The patient
has to be able to transmit the ECG through a land-
line phone, by playing the frequency modulated sig-
nal. Also, the patient has to remember to have the
monitor with him/her at all times [13]. Used infre-
quently, patients can forget how to use the device.
Another limitation is inability to capture asymptom-
atic events and inability to report arrhythmias in
a quantitative/numerical format. The latter means
that in cases of frequent transmission, the clinician
requires a lot of time to interpret the final/summa-
ry report.
Event monitoring: Looping memory
(EML) systems
EMLs are also patient-activated (symptoma-
tic) intermittent monitoring systems. The device has
a built-in looping memory in which the ECG signal
is constantly stored, with the oldest ECG samples
being overwritten by the newest. EMLs overcome
the biggest limitation of EMNLs in that they allow
for transmission of the pre-event signal, recovered
from the internal looping memory buffer. The in-
termittent looping memory monitors are used for
diagnosing patients with infrequent symptoms [14,
15], drug management, etc. In order to capture the
pre-event information, the patient has to wear the
monitor constantly with electrode patches attached
to the skin, which may cause irritation and allergic
reactions. Other limitations of EMLs are similar to
the limitations of the non-looping monitoring sys-
tems and include:
— limited internal memory, meaning inability to
store continuous ECG;
— inability to automatically capture asymptoma-
tic events;
— patient compliance: data has to be sent trans-
telephonically;
— inability to report arrhythmias in a quantitati-
ve format: reports may be extensive in size;
— high cost of report interpretation: the physician
has to review a significant number of reported
ECG strips;
— interaction from the patient may be required
to charge the batteries of the monitor.
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Atrial fibrillation auto-trigger monitoring
(AFM) systems
The next step in the evolution of the intermit-
tent monitoring systems is represented by AFMs.
This type of device is used for real-time monitor-
ing over an extended period  in order to detect in-
frequent arrhythmias. The devices allow for stor-
age and transmission of symptomatic and limited
types of asymptomatic events [16]. Similarly to
EMLs, this type of monitor has a built-in looping
memory for storing pre-event data, but also a built-
in Central Processor Unit that operates a simple
ECG analysis algorithm for measuring the patient’s
heart rate (HR). Based on the HR or R-R interval
criteria, the algorithm triggers storage of an event,
i.e. when the rate or the R-R interval falls below or
exceeds a specified threshold, or is irregular, then
the software makes a decision to record an ECG
strip. All the stored events are daily transmitted to
a healthcare provider. The algorithms embedded in
the AFM devices operate in real time, and do not
have the capability to recognize morphology of the
PQRST complexes. So, they cannot be used to de-
tect ventricular arrhythmias, which is their signifi-
cant limitation compared to the Holter systems. The
inability to classify the ECG morphology does not
allow for robust discrimination of the real ECG beats
from artifacts and other ECG disturbances, and may
lead to inaccurate measurements of HR or R-R in-
tervals. Except for the ability to store/transmit
some of the asymptomatic events, the limitations
of AFMs are similar to the limitations of EMLs and
include:
— limited internal memory means inability to sto-
re continuous ECG;
— potential skin irritation caused by the electro-
de patches;
— patient compliance: data has to be sent trans-
telephonically;
— inability to report arrhythmias in a quantitati-
ve format: the reports may be extensive in size
in case of frequent transmissions;
— high cost of report interpretation: the physician
has to review a significant number of reported
ECG strips;
— interaction from the patient is required to char-
ge the batteries of the monitor.
Mobile cardiac telemetry (MCT) systems
The newest incarnation of intermittent ECG
monitoring system is the MCT. Mobile cardiac
telemetry systems, as with all other intermittent
monitors, are used for real-time monitoring over an
extended period of time. MCTs are similar to
AFMs, but have a larger built-in memory that can
store more than 24 h of data. In addition, the de-
vice periodically triggers transmission of 30 s ECG
strips, so called ‘trending strips’. These strips are
sent every 10 min and are used for creating HR and
AF burden trends. Similarly to AFM devices, MCTs
utilize a simple real-time ECG interpretation algo-
rithm that detects a limited number of arrhythmias
based on the rate and R-R interval criteria. Patients
have the capability to transmit symptomatic events
in a similar manner to all other intermittent moni-
toring systems. Another advantage of the MCT
devices is the fact that they use the mobile telepho-
ny network infrastructure for data transmission.
This makes them simpler to use for the patient,
because there is no need to record events and then
send them via a landline phone to the monitoring
center/healthcare provider.
The transmission of the digital files uses file
transfer protocol and does not degrade the ECG
quality, which is another advantage of this techno-
logy. Also, once an event is detected, then the trans-
mission/upload is performed inside or outside the
patient’s home, assuming sufficient mobile network
coverage. This means that the patient can be truly
mobile and minimizes any delay between event
occurrence and actual transmission. The biggest
advantage of the MCT device is its ability to pro-
duce basic quantitative information regarding HR
and AF burden. This is useful for monitoring post-
-AF-ablation patients, patients undergoing antiar-
rhythmic drug therapy, or for detecting asymptom-
atic AF [12]. Yet at the same time the methodology
used for obtaining the quantitative information, i.e.
the methodology used for constructing the HR and
AF burden trends, is controversial and may be mis-
leading for the interpreting physician. This could be
considered as the biggest disadvantage of MCTs.
The MCT trends are calculated from the trending
strips — ECGs of 30 s duration transmitted every
10 min. This means that in fact the quantitative
trending information is extrapolated from 5% of the
actual ECG signal, which has significant numerical
consequences. The problem has been described in
the sampling theorem formulated by Theodor
Nyquist in 1924 [17, 18]. The sampling condition
introduced by Nyquist requires that in case of uni-
form sampling intervals (e.g. 10 min in the case of
MCT trends), the sampled components, i.e. the AF
episodes or sections with constant HR, should have
duration equal to or longer than 2 × 10 = 20 min. If
some of the episodes/sections with constant rate are
shorter than 20 min, then the extrapolated trend is
affected by so-called ‘aliasing error’. This means
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that if the sampling condition is not satisfied, then
it is not possible in general to discern an unambi-
guous signal — in this case the AF burden or HR
trend. Any component of the trends shorter than
20 min is indistinguishable from components lon-
ger than 20 min.
The aliasing error may be illustrated by the
following example: if the 30 s ECG sample used
for creating one value of the trend contains AF with
HR above 180 bpm, then it will be assumed that
10 min of the data contain constant AF with a rate
of 180 bpm, while in fact the duration of the epi-
sode may have been only 30 s. If similar aliasing
errors were repeated several times a day, e.g. if
30 out of a total of 144 trending strips transmitted
per day contained AF with a rate above 180 bpm,
then it would be represented by the MCT trends
as 300 min = 5 h of AF with a rate above 180 bpm,
while in fact the duration of AF with 180 bpm could
be only 15 min.
Another example is detection of paroxysmal
AF: AF episodes, if not captured by the trending
strips, would remain as undetected, which would
lead to potentially significant underestimation of the
total AF burden. If, similarly as in the first exam-
ple, 30 out of 144 trending strips did not contain AF,
then the trend would show 300 min = 5 h of non-
-AF signal, which is 21% of the total time per day,
while in fact it could be only 15 min of non-AF sig-
nal, which is 1% of 24 h. Other limitations of MCTs
are similar to the limitations of the other intermit-
tent monitoring systems and include:
— potential skin irritation caused by the electro-
de patches;
— high cost of report interpretation: the physician
has to review a significant number of ECG
strips included in the summary report;
— interaction from the patient is required to char-
ge the batteries of the monitor.
PocketECG: A new continuous and
real-time ambulatory arrhythmia
diagnostic method
The ‘PocketECG’ method utilizes a newly de-
veloped real-time and self-learning ECG interpre-
tation algorithm [19] that has the capability of de-
tecting QRS complexes and classifying the heart-
beats’ morphology in real time with a delay not
exceeding 3.5 s. The algorithm’s efficacy has been
measured using standard ECG signas databases
[20–22] in accordance with the ANSI/AAMI
EC57:1998/(R)2003 requirements. AF detection
efficacy yields are: AF Se, AF+P: 94.6% and 95.1%
respectively. QRS detection and morphology classi-
fication efficacy yields are: QRS Se, QRS+P, VEB Se
and VEB+P: 99.6%, 99.7%, 93.5% and 93.5% re-
spectively for the AHA database [22] and 99.6%,
99.5%, 94.1% and 91.4% respectively for the MIT-BIH
database [22].
Technical challenges of the new approach
The achieved efficacy is comparable to that of
the most effective Holter system. However, these
results are generated in real-time with a 3.5 s de-
lay, while the Holter applications work in an offline
setup — the signal has to be collected first and then
processed. Obtaining this level of accuracy in a real-
-time setup is a major technical challenge, and from
a digital signal processing algorithm design perspec-
tive it is a more complex challenge. The complexity
is caused by the fact that the algorithm has to have
the ability to automatically learn the signal and cre-
ate its own morphology templates, based on which
all classification decisions are made autonomously.
Prior to creating the templates, one of the crucial ele-
ments of the preprocessing stage is an effective way
of discriminating useful ECG signal from disturbanc-
es and broadband noise. The developed ECG inter-
pretation engine utilizes an unpredictability measure
(UM) algorithm [23] — a technique used in advanced
psychoacoustics and perceptual audio coding appli-
cations. The UM algorithm can be successfully ap-
plied to ECG preprocessing, because the ECG sig-
nal has a quasi-periodic character similar to that of
audio waveforms. This means that the chaotic/ran-
dom phase of complex numbered spectrum compo-
nents represents parasite noise and therefore can be
distinguished using the UM method. The unpredict-
ability value of the complex numbered spectral bin
is calculated in the following way:
For tkr denoting spectral magnitude and 
t
kΦ
denoting phase, both at time t, while tkrˆ  and 
t
kΦˆ
represent the predicted values of tkΦ , and are re-
ferred to the past information — calculated for two
previous signal sample frames:
Spectrum of three consecutive periods of ECG
is shown in the upper part of Figure 1. The UM
graph calculated for all spectrum bins is shown in
the lower part of Figure 1.
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The spectrum and the UM curve of the same
signal, but contaminated with artificially added
Gaussian white noise, are shown in Figure 2.
It can be seen that the local maxima of the spec-
trum from the upper part of Figure 1 correspond with
the local minima (low UM values) from the lower part
of Figure 1. In the noisy signal from Figure 2, the
high magnitude level of the spectrum bins present-
ed in the upper part does not correspond with the
low UM values shown in the lower part. Since the
Figure 2. Spectrum (upper) and unpredictability measure (UM) graph (lower) of noisy ECG waveform.
Figure 1. Spectrum (upper) and unpredictability measure (UM) graph (lower) of clean ECG waveform.
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sinusoidal components forming the clean, quasi-pe-
riodic ECG waveform contain the most signal ener-
gy, they are reflected by the UM values close to zero.
Hence, the UM weighted noise energy estimate for
time t can be estimated in the following way:
where: X is the ECG block spectrum, t is the time
instance, k is the spectrum bin index and E the
is noise energy estimate.
Advantages and disadvantages of
the new arrhythmia diagnostic method
The main advantage of the new method is that
it combines the main advantages of the continuous
method of Holter diagnostics with the advantages
of all the real-time, intermittent diagnostic solu-
tions. The new method automatically recognizes
PQRST morphology and counts all of the pathologi-
cal and normal beats. The report format of the new
method is presented in Figure 3. The device
streams the entire ECG signal through the mobile
telephony network for instant access. The system
allows for reporting the results in a numerical for-
mat, similarly to Holter applications, where the
front page of the report summarizes the analysis of
results of hundreds of thousands of heartbeats col-
lected over several weeks (Fig. 3).
The report can be supported by selected ECG
examples, as in the Holter systems. This way of
presenting the diagnostic results saves the physi-
cian’s time, hence reducing the report interpreta-
tion cost. Patients have the capability to mark symp-
tomatic events, similarly as with all the reviewed
intermittent monitoring systems. But correlation of
the symptomatic events with the asymptomatic
Figure 3. Example of front page of summary report of PocketECG, the new arrhythmia diagnostic method.
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events is summarized using the numerical format
on the front page of the report (see the Symptomatic
section in Fig. 3). Since it is a real-time method, it
allows for remote and real-time access to the beat-
-by-beat, hourly and daily HR and AF burden data.
It is especially useful for monitoring post-AF-
-ablation patients, patients undergoing antiarrhyth-
mic drug therapy, or for detecting asymptomatic
AF. It also allows for real-time access to detailed
analysis results related to all other arrhythmias, in-
cluding supraventricular and ventricular events
(Fig. 3). All of the arrhythmia statistics, including
AF burden and AF rate analysis, are based on the
detection of single ECG beats, similarly as in the
Holter applications i.e. the results are not extrapo-
lated from limited/sampled data. The limitations of
the PocketECG system include:
— potential skin irritation caused by the electro-
de patches;
— required interaction from the patient to char-
ge the batteries of the monitor.
Conclusions
The new continuous and real-time ambulatory
arrhythmia diagnostic system presented in this arti-
cle overcomes most of the limitations typical of the
existing non-invasive ambulatory arrhythmia diag-
nostic methods. It provides numerical/quantitative
reporting capabilities and access to a continuous ECG
signal, similarly to the Holter applications, combined
with the capability of monitoring patients over an
extended period  and with the capability to access
the data and the diagnosis results in real-time.
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